Mar 21, 2017 11:02 am UTC| Business
OKLAHOMA CITY, March 21, 2017 -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ:TUSK) announced today that it has entered into definitive agreements to acquire Sturgeon Acquisitions, LLC (which owns...
Mar 21, 2017 11:02 am UTC| Business
OKLAHOMA CITY, March 21, 2017 -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ:TUSK) announced today that it has entered into definitive agreements to acquire Sturgeon Acquisitions, LLC (which owns...
Mar 21, 2017 11:02 am UTC| Business
OKLAHOMA CITY, March 21, 2017 -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ:TUSK) announced today that it has entered into definitive agreements to acquire Sturgeon Acquisitions, LLC (which owns...
Mar 21, 2017 11:02 am UTC| Business
- EMA guidance provides clear regulatory pathway for EU approval for Iomab-B - Trial design, primary endpoint and planned statistical analysis from the Iomab-B U.S. pivotal Phase 3 SIERRA trial are acceptable as the...
Mar 21, 2017 11:02 am UTC| Business
- EMA guidance provides clear regulatory pathway for EU approval for Iomab-B - Trial design, primary endpoint and planned statistical analysis from the Iomab-B U.S. pivotal Phase 3 SIERRA trial are acceptable as the...
Mar 21, 2017 11:02 am UTC| Business
- EMA guidance provides clear regulatory pathway for EU approval for Iomab-B - Trial design, primary endpoint and planned statistical analysis from the Iomab-B U.S. pivotal Phase 3 SIERRA trial are acceptable as the...
OncoCyte Submits Application for CLIA Certification of its Laboratory
Mar 21, 2017 11:02 am UTC| Business
ALAMEDA, Calif., March 21, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests to aid in the early detection of cancer, has submitted its application for CLIA certification...